Magnhild Sandberg Wollheim
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Cognitive dysfunction 24-31 years after isolated optic neuritis.
(
- Contribution to journal › Article
-
Mark
Nordic trial of methylprednisolone as add-on therapy to interferon-beta for the treatment of relapsing-remitting multiple sclerosis
2008) 13th Annnual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis In Multiple Sclerosis Journal 14. p.299-300(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis
(
- Contribution to journal › Article
-
Mark
A follow-up study of Nordic multiple sclerosis candidate gene regions
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Article
- 2006
-
Mark
Health-related quality of life in secondary progressive multiple sclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
(
- Contribution to journal › Article
- 2005
-
Mark
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis - The EVIDENCE study
(
- Contribution to journal › Article
-
Mark
Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
(
- Contribution to journal › Article
-
Mark
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
(
- Contribution to journal › Article